TheraSphere & Treatment of Unresectable Primary or Unresectable Secondary Liver Cancer

Clinical trial NCT04090645 · COMPLETED

Trial details

NCT number: NCT04090645
Sponsor: Methodist Health System
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Liver, Cancer of, Non-Resectable

Start date: 2014-05-22
Primary completion: 2021-04-16
Enrollment: 187

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.